Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference

Journal of Hepatology(2023)10.1016/j.jhep.2023.06.002Source: DataRank Database

Guidance on treatment endpoints and study design for clinical trials aiming to achieve cure in chronic hepatitis B and D: Report from the 2022 AASLD-EASL HBV-HDV Treatment Endpoints Conference is a research paper published in Journal of Hepatology (2023). On theSindex it has a DataRank of 0. It has been cited 103 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access103 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 18.25)OA: bronzeTopics (47)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Maria Buti ORCID,Pietro Lampertico ORCID,Hannah M. Lee ORCID,Marc G. Ghany ORCID

Live enrichment

PubMed:37377088 OpenAlex:https://openalex.org/W4381513876

World Health Organization

Grant: 001

Intramural NIH HHS

Grant: ZIA DK054517

FWCI

18.25

Citation Percentile

1.0%

Citation Trend

2023

2024

2025

2026

bronzeLicense: https://www.elsevier.com/legal/tdmrep-license

journalhttp://www.journal-of-hepatology.eu/article/S0168827823004178/pdf

publisherhttp://www.journal-of-hepatology.eu/article/S0168827823004178/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0168827823004178?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0168827823004178?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jhep.2023.06.002

Fields of Study

Hepatitis B Virus StudiesHepatitis C virus researchLiver Disease Diagnosis and TreatmentHumansHepatitis B, ChronicAntiviral AgentsHepatitis D, ChronicHepatitis Delta VirusResearch DesignClinical Trials as TopicDNA, ViralHepatitis B virusHepatitis B Surface AntigensEndpoint DeterminationTreatment OutcomeClinical Trials, Phase II as Topic

MeSH Terms

Antiviral AgentsClinical Trials as TopicHepatitis Delta VirusDNA, ViralHepatitis B Surface AntigensHepatitis B virusHumansResearch DesignTreatment OutcomeClinical Trials, Phase II as TopicHepatitis B, ChronicHepatitis D, ChronicEndpoint Determination

Keywords

MedicineClinical endpointHBsAgClinical trialInternal medicineHepatitis BChronic hepatitisSurrogate endpointHBeAgcccDNAHepatitis D virusHepatitis B virusGastroenterologyImmunologyVirusHBVHDVdiagnosis